JP MORGAN/PUT/PFIZER INC/22/0.1/16.01.26 Stock

Warrant

DE000JK46A78

Real-time Bid/Ask 08:05:04 2024-07-12 EDT
0.13 EUR / 0.14 EUR -3.57% Intraday chart for JP MORGAN/PUT/PFIZER INC/22/0.1/16.01.26
Current month-12.50%
1 month-6.67%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-11 0.14 -6.67%
24-07-10 0.15 0.00%
24-07-09 0.15 +7.14%
24-07-08 0.14 -6.67%
24-07-05 0.15 0.00%

Delayed Quote Börse Stuttgart

Last update July 11, 2024 at 05:53 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying PFIZER, INC.
Issuer J.P. Morgan
WKN JK46A7
ISINDE000JK46A78
Date issued 2024-03-01
Strike 22 $
Maturity 2026-01-16 (553 Days)
Parity 10 : 1
Emission price 0.19
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.24
Lowest since issue 0.12
Delta-0.19x
Omega 3.685
Premium28.37x
Gearing19.49x
Moneyness 0.7676
Difference Strike -6.66 $
Difference Strike %-30.27%
Spread 0.01
Spread %7.14%
Theoretical value 0.1350
Implied Volatility 32.01 %
Total Loss Probability 66.86 %
Intrinsic value 0.000000
Present value 0.1350
Break even 20.53 €
Theta-0x
Vega0.01x
Rho-0.01x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.66 USD
Average target price
32.01 USD
Spread / Average Target
+11.68%
Consensus